Physician profile
Roberto Roizenblatt
NPI 1952564064
$3,991.10
in general payments reported to CMS, 2019-2025
17 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $474 · 2020: $371 · 2021: $744 · 2022: $429 · 2023: $392 · 2024: $917 · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913 · Entertainment: $59.66.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.18 |
| Entertainment | $59.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,397.10 | 2019-2025 | Eylea Hd |
| Alcon Vision LLC | $891.43 | 2019-2025 | Constellation, Ngenuity |
| Astellas Pharma US INC | $657.23 | 2023-2025 | Izervay |
| Genentech USA, INC. | $242.89 | 2019-2025 | Vabysmo |
| Alimera Sciences, INC. | $153.88 | 2020-2024 | Iluvien, Yutiq |
| Novartis Pharmaceuticals Corporation | $120.76 | 2019 | |
| Apellis Pharmaceuticals, INC. | $115.70 | 2023-2025 | Syfovre |
| Carl Zeiss Meditec USA, INC. | $111.85 | 2022 | |
| Eyepoint US, INC. | $72.84 | 2021-2022 | |
| Optos, INC. | $59.66 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $56.87 | 2020-2021 | |
| Sandoz INC. | $23.83 | 2024 | Cimerli |
| Tarsus Pharmaceuticals, INC. | $21.55 | 2025 | Xdemvy |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Aerie Pharmaceuticals, INC. | $17.43 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $17.03 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Roizenblatt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.